BRAF and neoplasm: In another study, the metastasis of a primary tumor bearing an immunogenic BRAF clonal neoantigen (V599E) induced an HLA-restricted cytotoxic T cell response to the clonal BRAF neoantigen in the metastatic lesion as the inciting event.